Emerging technologies and clinical research in Latin America


Wednesday 18 November at 16:00 (UTC)

About this video

Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. In 2013 and 2015The Lancet Oncology published two Commissions that highlighted the cancer landscape in Latin America and how it differed from more developed countries. The reports showed that funding for health care was just a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower.

Funding, insurance coverage, numbers of doctors, health-care workers, resources, and equipment were inequitably distributed between and within Latin American countries. The Commissions emphasised the need for structural reforms in health-care systems, the need for dedicated cancer control programmes for disenfranchised populations, the importance of expanding coverage of cancer registries and cancer plans, and the effect of implementing policies to improve primary cancer prevention. In this webinar, renowned experts from Brazil, Argentina, and Spain, revisit cancer control in Latin America via a more contemporaneous lens, with a focus on the challenges surrounding academic research funding, clinical trial recruitment, big data, and wider access to the latest diagnostic technologies.


About the presenter

David Collingridge

Editor-in-Chief, The Lancet Oncology

Dr David Collingridge has been Editor-in-Chief of The Lancet Oncology since March 2002 and is also the Publishing Director for The Lancet’s specialty journals. Prior to his appointments at The Lancet, he gained a PhD in Tumour Biology from the Gray Cancer Institute/University College London, UK, and held research posts in the Department of Therapeutic Radiology, Yale University, CT, USA, and in the PET Oncology Group, Imperial College School of Medicine, Hammersmith Hospital, London, UK. Dr Collingridge has won several awards for projects focused on cancer control in low-to-middle income countries; has published numerous peer-review articles, editorials, opinion pieces, and news reports; and has co-authored a text book on radiobiology. He currently also holds the position of Clinical Associate Professor of Radiation Medicine at Hofstra/Northwell Health, Lake Success, NY, USA.


Prof Eduado Cazap

Latin-American & Caribbean Society of Medical Oncology, Buenos Aires, Argentina

Eduardo L. Cazap, MD, PhD, is the founder and first president of the Latin American and Caribbean Society of Medical Oncology (SLACOM), the immediate past president of the International Union against Cancer (UICC), and the recently designated deputy chair of the Developing Countries Task Force of the European Society of Medical Oncology. He is internationally known as a regular speaker, chair, and/or moderator at global cancer and health meetings and for organizing major international conferences. Dr. Cazap’s leadership has helped push cancer and world health into the international political agenda. In 2011, largely due to the work of the UICC and other international cancer organizations, the United Nations held an unprecedented high-level meeting on cancer and other noncommunicable diseases. Dr. Cazap served as co-chair of the United Nations Civil Society Task Force to advise the President of the United Nations General Assembly during this meeting. In September 2010, Dr. Cazap was designated by the Argentinean government as a member of the Executive Board of the newly created National Cancer Institute of Argentina. Dr. Cazap’s main areas of research and interest are global health, cancer control and prevention, breast and cervical cancer, and independent clinical research. ASCO is pleased to recognize Dr. Cazap for his extraordinary leadership in the field of oncology and for his profound contribution to global cancer care.

Dr Carlos Barrios

Centro de Pesquisa em Oncologia, Hospital São Lucas, Porto Alegre, Brazil

Dr. Barrios has been a Professor of the Internal Medicine Department and the Director of the Oncology Research Unit at Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) in  Porto Alegre, Brazil, since 1991. Currently Dr. Barrios is also the Director of the Cancer Institute at the Hospital Mãe de Deu in Porto Alegre and the Director of the Latin American Clinical Oncology Research Group (GLICO).


Dr. Barrios graduated from the Pontifícia Universidade Católica do Rio Grande do Sul in 1979. After training in Internal Medicine at Jackson Memorial Hospital (University of Miami, Florida) from 1982-1985, he went on to complete a Hematology and Oncology Fellowship at Barnes/Jewish Hospitals (Washington University, St. Louis, Missouri) from 1985-1988. He was a Clinical Instructor in the Department of Medicine at Washington University in 1989. He has obtained the following certifications: ECFMG (1978); VQE (1981); FLEX; Board of Medical Examiners, Florida (1985); American Board of Internal Medicine (1986); American Board of Oncology (1987); and American Board of Hematology (1988).


Dr. Barrios has been an Adjuvant Assistant Professor of the Department of Medicine at the University of Miami School of Medicine since 1990 and the local representative of the William J. Harrington Latin American Program. He has participated in many clinical trials over the last 10 years. He has numerous publications in professional medical journals and is often invited as a speaker at cancer congresses worldwide.